Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
KALA BIO, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
KALA
Nasdaq
2836
www.kalarx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for KALA BIO, Inc.
KALA BIO Announces $10,750,000 Private Placement
- Dec 30th, 2024 1:00 pm
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
- Nov 27th, 2024 1:00 pm
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Nov 12th, 2024 1:00 pm
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Aug 8th, 2024 12:00 pm
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Aug 6th, 2024 12:00 pm
KALA BIO Announces $12,500,000 Private Placement
- Jun 27th, 2024 12:00 pm
KALA BIO to Present at Jefferies Global Healthcare Conference
- May 29th, 2024 12:00 pm
Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)
- May 21st, 2024 5:13 pm
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
- May 14th, 2024 8:05 pm
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Mar 29th, 2024 12:00 pm
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- Feb 26th, 2024 1:00 pm
Scroll